Montreal, July 21, 2025 — NewsWall — Cannara Biotech Inc. will release its financial results for the fiscal third quarter ended May 31, 2025, on Monday, July 28, 2025, at 7:00 a.m. ET.
Cannara Biotech’s CFO, Nicholas Sosiak, will host an earnings webcast on Monday, July 28, 2025 at 11 a.m. ET., consisting of prepared remarks followed by a live question-and-answer session.
Participants can register for the conference call and webcast here or on the Cannara Biotech website. The event will be archived on the company’s website for those unable to attend.
Investors are encouraged to submit questions in advance to investors@cannara.ca. While live questions will be accepted during the session, priority will be given to those submitted by email.
Nicholas Sosiak, CPA, CA, Chief Financial Officer, nick@cannara.ca
Zohar Krivorot, President & Chief Executive Officer, zohar@cannara.ca
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), is a vertically integrated producer of premium-grade cannabis products at disruptive prices for the Canadian market. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output.
Leveraging Québec’s low electricity costs, Cannara’s facilities produce premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.
Source: Cannara Biotech Inc.
